Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment

Franco Molina, Moisés Armides y Miranda Hernández, Diana Fabiola y Mendoza Gamboa, Edgar y Zapata Benavides, Pablo y Coronado Cerda, Erika Evangelina y Sierra Rivera, Crystel Aleyvick y Saavedra Alonso, Santiago y Tamez Guerra, Reyes Silvestre y Rodríguez Padilla, Cristina (2016) Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment. OncoTargets and Therapy (1). pp. 243-253. ISSN 1178-6930

Vista previa

Texto
23830.pdf - Versión Aceptada
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (1MB) | Vista previa

URL o página oficial: http://doi.org/10.2147/OTT.S90476

Resumen

Forkhead box p3 (Foxp3) expression was believed to be specific for T-regulatory cells but has recently been described in non-hematopoietic cells from different tissue origins and in tumor cells from both epithelial and non-epithelial tissues. The aim of this study was to elucidate the role of Foxp3 in murine melanoma. The B16F10 cell line Foxp3 silenced with small interference Foxp3 plasmid transfection was established and named B16F10.1. These cells had lower levels of Foxp3 mRNA (quantitative real-time reverse transcription-polymerase chain reaction [0.235-fold]), protein (flow cytometry [0.02%]), CD25+ expression (0.06%), cellular proliferation (trypan blue staining), and interleukin (IL)-2 production (enzyme-linked immunosorbent assay [72.35 pg/mL]) than those in B16F10 wild-type (WT) cells (P<0.05). Subcutaneous inoculation of the B16F10.1 cell line into C57BL/6 mice delayed the time of visible tumor appearance, increased the time of survival, and affected the weight of tumors, and also decreased the production of IL-10, IL-2, and transforming growth factor beta compared with mice inoculated with the B16F10 WT cell line. The B16F10.1 cells derived from tumors and free of T-cells (isolated by Dynabeads and plastic attachment) expressed relatively lower levels of Foxp3 and CD25+ than B16F10 WT cells (P<0.05) in a time-dependent manner. The population of tumor-infiltrating lymphocytes of T CD4+ cells (CD4+, CD4+CD25+, and CD4+CD25+Foxp3+) increased in a time-dependent manner (P<0.05) in tumors derived from B16F10 WT cells and decreased in tumors derived from B16F10.1 cells. Similar data were obtained from spleen cells. These results suggest that, in melanomas, Foxp3 partly induces tumor growth by modifying the immune system at the local and peripheral level, shifting the environment toward an immunosuppressive profile. Therapies incorporating this transcription factor could be strategies for cancer treatment.

Tipo de elemento:

Article

Palabras claves no controlados:

melanoma, Foxp3, cáncer, células T reguladoras

Materias:

R Medicina > RC Medicina Interna, Psiquiatría, Neurología

Divisiones:

Ciencias Biológicas

Usuario depositante:

Editor Repositorio

Creadores:

Creador	Email	ORCID
Franco Molina, Moisés Armides	NO ESPECIFICADO	NO ESPECIFICADO
Miranda Hernández, Diana Fabiola	NO ESPECIFICADO	NO ESPECIFICADO
Mendoza Gamboa, Edgar	edgar.mendozagm@uanl.edu.mx	orcid.org/0000-0002-0827-5717
Zapata Benavides, Pablo	NO ESPECIFICADO	NO ESPECIFICADO
Coronado Cerda, Erika Evangelina	NO ESPECIFICADO	NO ESPECIFICADO
Sierra Rivera, Crystel Aleyvick	NO ESPECIFICADO	NO ESPECIFICADO
Saavedra Alonso, Santiago	NO ESPECIFICADO	NO ESPECIFICADO
Tamez Guerra, Reyes Silvestre	NO ESPECIFICADO	NO ESPECIFICADO
Rodríguez Padilla, Cristina	NO ESPECIFICADO	NO ESPECIFICADO